Medical Devices

Global Liver Cirrhosis Therapeutics Drugs Market Size, Status and Forecast 2018-2025

  • QYR2790501
  • 100 Pages
  • October 2018
  • Medical Devices
Download Sample    Get Discount   
 
In 2017, the global Liver Cirrhosis Therapeutics Drugs market size was million US$ and it is expected to reach million US$ by the end of 2025, with a CAGR of during 2018-2025.

This report focuses on the global Liver Cirrhosis Therapeutics Drugs status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Liver Cirrhosis Therapeutics Drugs development in United States, Europe and China.

The key players covered in this study

Gilead Sciences

GlaxoSmithKline

Johnson & Johnson

Merck

Roche

Bristol-Myers Squibb

Conatus Pharmaceuticals

Gwo Xi Stem Cell Applied Technology

Instituto Grifols

Intercept Pharmaceuticals

NGM Biopharmaceuticals

Norgine

Pharmicell

Salix Pharmaceuticals

Stempeutics Research

Market segment by Type, the product can be split into

Oral

Injection

Market segment by Application, split into

Hospitals

Clinics

Other

Market segment by Regions/Countries, this report covers

United States

Europe

China

Japan

Southeast Asia

India

Central & South America

The study objectives of this report are:

To analyze global Liver Cirrhosis Therapeutics Drugs status, future forecast, growth opportunity, key market and key players.

To present the Liver Cirrhosis Therapeutics Drugs development in United States, Europe and China.

To strategically profile the key players and comprehensively analyze their development plan and strategies.

To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Liver Cirrhosis Therapeutics Drugs are as follows:

History Year: 2013-2017

Base Year: 2017

Estimated Year: 2018

Forecast Year 2018 to 2025

For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Table of Contents

1 Report Overview

1.1 Study Scope

1.2 Key Market Segments

1.3 Players Covered

1.4 Market Analysis by Type

1.4.1 Global Liver Cirrhosis Therapeutics Drugs Market Size Growth Rate by Type (2013-2025)

1.4.2 Oral

1.4.3 Injection

1.5 Market by Application

1.5.1 Global Liver Cirrhosis Therapeutics Drugs Market Share by Application (2013-2025)

1.5.2 Hospitals

1.5.3 Clinics

1.5.4 Other

1.6 Study Objectives

1.7 Years Considered

2 Global Growth Trends

2.1 Liver Cirrhosis Therapeutics Drugs Market Size

2.2 Liver Cirrhosis Therapeutics Drugs Growth Trends by Regions

2.2.1 Liver Cirrhosis Therapeutics Drugs Market Size by Regions (2013-2025)

2.2.2 Liver Cirrhosis Therapeutics Drugs Market Share by Regions (2013-2018)

2.3 Industry Trends

2.3.1 Market Top Trends

2.3.2 Market Drivers

2.3.3 Market Opportunities

3 Market Share by Key Players

3.1 Liver Cirrhosis Therapeutics Drugs Market Size by Manufacturers

3.1.1 Global Liver Cirrhosis Therapeutics Drugs Revenue by Manufacturers (2013-2018)

3.1.2 Global Liver Cirrhosis Therapeutics Drugs Revenue Market Share by Manufacturers (2013-2018)

3.1.3 Global Liver Cirrhosis Therapeutics Drugs Market Concentration Ratio (CR5 and HHI)

3.2 Liver Cirrhosis Therapeutics Drugs Key Players Head office and Area Served

3.3 Key Players Liver Cirrhosis Therapeutics Drugs Product/Solution/Service

3.4 Date of Enter into Liver Cirrhosis Therapeutics Drugs Market

3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application

4.1 Global Liver Cirrhosis Therapeutics Drugs Market Size by Type (2013-2018)

4.2 Global Liver Cirrhosis Therapeutics Drugs Market Size by Application (2013-2018)

5 United States

5.1 United States Liver Cirrhosis Therapeutics Drugs Market Size (2013-2018)

5.2 Liver Cirrhosis Therapeutics Drugs Key Players in United States

5.3 United States Liver Cirrhosis Therapeutics Drugs Market Size by Type

5.4 United States Liver Cirrhosis Therapeutics Drugs Market Size by Application

6 Europe

6.1 Europe Liver Cirrhosis Therapeutics Drugs Market Size (2013-2018)

6.2 Liver Cirrhosis Therapeutics Drugs Key Players in Europe

6.3 Europe Liver Cirrhosis Therapeutics Drugs Market Size by Type

6.4 Europe Liver Cirrhosis Therapeutics Drugs Market Size by Application

7 China

7.1 China Liver Cirrhosis Therapeutics Drugs Market Size (2013-2018)

7.2 Liver Cirrhosis Therapeutics Drugs Key Players in China

7.3 China Liver Cirrhosis Therapeutics Drugs Market Size by Type

7.4 China Liver Cirrhosis Therapeutics Drugs Market Size by Application

8 Japan

8.1 Japan Liver Cirrhosis Therapeutics Drugs Market Size (2013-2018)

8.2 Liver Cirrhosis Therapeutics Drugs Key Players in Japan

8.3 Japan Liver Cirrhosis Therapeutics Drugs Market Size by Type

8.4 Japan Liver Cirrhosis Therapeutics Drugs Market Size by Application

9 Southeast Asia

9.1 Southeast Asia Liver Cirrhosis Therapeutics Drugs Market Size (2013-2018)

9.2 Liver Cirrhosis Therapeutics Drugs Key Players in Southeast Asia

9.3 Southeast Asia Liver Cirrhosis Therapeutics Drugs Market Size by Type

9.4 Southeast Asia Liver Cirrhosis Therapeutics Drugs Market Size by Application

10 India

10.1 India Liver Cirrhosis Therapeutics Drugs Market Size (2013-2018)

10.2 Liver Cirrhosis Therapeutics Drugs Key Players in India

10.3 India Liver Cirrhosis Therapeutics Drugs Market Size by Type

10.4 India Liver Cirrhosis Therapeutics Drugs Market Size by Application

11 Central & South America

11.1 Central & South America Liver Cirrhosis Therapeutics Drugs Market Size (2013-2018)

11.2 Liver Cirrhosis Therapeutics Drugs Key Players in Central & South America

11.3 Central & South America Liver Cirrhosis Therapeutics Drugs Market Size by Type

11.4 Central & South America Liver Cirrhosis Therapeutics Drugs Market Size by Application

12 International Players Profiles

12.1 Gilead Sciences

12.1.1 Gilead Sciences Company Details

12.1.2 Company Description and Business Overview

12.1.3 Liver Cirrhosis Therapeutics Drugs Introduction

12.1.4 Gilead Sciences Revenue in Liver Cirrhosis Therapeutics Drugs Business (2013-2018)

12.1.5 Gilead Sciences Recent Development

12.2 GlaxoSmithKline

12.2.1 GlaxoSmithKline Company Details

12.2.2 Company Description and Business Overview

12.2.3 Liver Cirrhosis Therapeutics Drugs Introduction

12.2.4 GlaxoSmithKline Revenue in Liver Cirrhosis Therapeutics Drugs Business (2013-2018)

12.2.5 GlaxoSmithKline Recent Development

12.3 Johnson & Johnson

12.3.1 Johnson & Johnson Company Details

12.3.2 Company Description and Business Overview

12.3.3 Liver Cirrhosis Therapeutics Drugs Introduction

12.3.4 Johnson & Johnson Revenue in Liver Cirrhosis Therapeutics Drugs Business (2013-2018)

12.3.5 Johnson & Johnson Recent Development

12.4 Merck

12.4.1 Merck Company Details

12.4.2 Company Description and Business Overview

12.4.3 Liver Cirrhosis Therapeutics Drugs Introduction

12.4.4 Merck Revenue in Liver Cirrhosis Therapeutics Drugs Business (2013-2018)

12.4.5 Merck Recent Development

12.5 Roche

12.5.1 Roche Company Details

12.5.2 Company Description and Business Overview

12.5.3 Liver Cirrhosis Therapeutics Drugs Introduction

12.5.4 Roche Revenue in Liver Cirrhosis Therapeutics Drugs Business (2013-2018)

12.5.5 Roche Recent Development

12.6 Bristol-Myers Squibb

12.6.1 Bristol-Myers Squibb Company Details

12.6.2 Company Description and Business Overview

12.6.3 Liver Cirrhosis Therapeutics Drugs Introduction

12.6.4 Bristol-Myers Squibb Revenue in Liver Cirrhosis Therapeutics Drugs Business (2013-2018)

12.6.5 Bristol-Myers Squibb Recent Development

12.7 Conatus Pharmaceuticals

12.7.1 Conatus Pharmaceuticals Company Details

12.7.2 Company Description and Business Overview

12.7.3 Liver Cirrhosis Therapeutics Drugs Introduction

12.7.4 Conatus Pharmaceuticals Revenue in Liver Cirrhosis Therapeutics Drugs Business (2013-2018)

12.7.5 Conatus Pharmaceuticals Recent Development

12.8 Gwo Xi Stem Cell Applied Technology

12.8.1 Gwo Xi Stem Cell Applied Technology Company Details

12.8.2 Company Description and Business Overview

12.8.3 Liver Cirrhosis Therapeutics Drugs Introduction

12.8.4 Gwo Xi Stem Cell Applied Technology Revenue in Liver Cirrhosis Therapeutics Drugs Business (2013-2018)

12.8.5 Gwo Xi Stem Cell Applied Technology Recent Development

12.9 Instituto Grifols

12.9.1 Instituto Grifols Company Details

12.9.2 Company Description and Business Overview

12.9.3 Liver Cirrhosis Therapeutics Drugs Introduction

12.9.4 Instituto Grifols Revenue in Liver Cirrhosis Therapeutics Drugs Business (2013-2018)

12.9.5 Instituto Grifols Recent Development

12.10 Intercept Pharmaceuticals

12.10.1 Intercept Pharmaceuticals Company Details

12.10.2 Company Description and Business Overview

12.10.3 Liver Cirrhosis Therapeutics Drugs Introduction

12.10.4 Intercept Pharmaceuticals Revenue in Liver Cirrhosis Therapeutics Drugs Business (2013-2018)

12.10.5 Intercept Pharmaceuticals Recent Development

12.11 NGM Biopharmaceuticals

12.12 Norgine

12.13 Pharmicell

12.14 Salix Pharmaceuticals

12.15 Stempeutics Research

13 Market Forecast 2018-2025

13.1 Market Size Forecast by Regions

13.2 United States

13.3 Europe

13.4 China

13.5 Japan

13.6 Southeast Asia

13.7 India

13.8 Central & South America

13.9 Market Size Forecast by Product (2018-2025)

13.10 Market Size Forecast by Application (2018-2025)

14 Analyst's Viewpoints/Conclusions

15 Appendix

15.1 Research Methodology

15.1.1 Methodology/Research Approach

15.1.1.1 Research Programs/Design

15.1.1.2 Market Size Estimation

12.1.1.3 Market Breakdown and Data Triangulation

15.1.2 Data Source

15.1.2.1 Secondary Sources

15.1.2.2 Primary Sources

15.2 Disclaimer

15.3 Author Details

List of Tables and Figures

Table Liver Cirrhosis Therapeutics Drugs Key Market Segments

Table Key Players Liver Cirrhosis Therapeutics Drugs Covered

Table Global Liver Cirrhosis Therapeutics Drugs Market Size Growth Rate by Type 2013-2025 (Million US$)

Figure Global Liver Cirrhosis Therapeutics Drugs Market Size Market Share by Type 2013-2025

Figure Oral Figures

Table Key Players of Oral

Figure Injection Figures

Table Key Players of Injection

Table Global Liver Cirrhosis Therapeutics Drugs Market Size Growth by Application 2013-2025 (Million US$)

Figure Hospitals Case Studies

Figure Clinics Case Studies

Figure Other Case Studies

Figure Liver Cirrhosis Therapeutics Drugs Report Years Considered

Table Global Liver Cirrhosis Therapeutics Drugs Market Size 2013-2025 (Million US$)

Figure Global Liver Cirrhosis Therapeutics Drugs Market Size and Growth Rate 2013-2025 (Million US$)

Table Global Liver Cirrhosis Therapeutics Drugs Market Size by Regions 2013-2025 (Million US$)

Table Global Liver Cirrhosis Therapeutics Drugs Market Size by Regions 2013-2018 (Million US$)

Table Global Liver Cirrhosis Therapeutics Drugs Market Share by Regions 2013-2018

Figure Global Liver Cirrhosis Therapeutics Drugs Market Share by Regions 2013-2018

Figure Global Liver Cirrhosis Therapeutics Drugs Market Share by Regions 2018

Table Market Top Trends

Table Global Liver Cirrhosis Therapeutics Drugs Revenue by Manufacturers (2013-2018) (Million US$)

Table Global Liver Cirrhosis Therapeutics Drugs Market Share by Manufacturers (2013-2018)

Figure Global Liver Cirrhosis Therapeutics Drugs Market Share by Manufacturers in 2018

Table Global Liver Cirrhosis Therapeutics Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)

Table Key Players Head office and Area Served

Table Key Players Liver Cirrhosis Therapeutics Drugs Product/Solution/Service

Table Date of Enter into Liver Cirrhosis Therapeutics Drugs Market

Table Mergers & Acquisitions, Expansion Plans

Table Global Liver Cirrhosis Therapeutics Drugs Market Size by Type (2013-2018) (Million US$)

Table Global Liver Cirrhosis Therapeutics Drugs Market Size Share by Type (2013-2018)

Figure Global Liver Cirrhosis Therapeutics Drugs Market Size Market Share by Type (2013-2018)

Table Global Liver Cirrhosis Therapeutics Drugs Market Size by Application (2013-2018) (Million US$)

Table Global Liver Cirrhosis Therapeutics Drugs Market Size Share by Application (2013-2018)

Figure Global Liver Cirrhosis Therapeutics Drugs Market Size Market Share by Application (2013-2018)

Figure Global Liver Cirrhosis Therapeutics Drugs Revenue Market Share by Application in 2017

Figure United States Liver Cirrhosis Therapeutics Drugs Market Size 2013-2018 (Million US$)

Table United States Key Players Liver Cirrhosis Therapeutics Drugs Revenue (2017-2018) (Million US$)

Table United States Key Players Liver Cirrhosis Therapeutics Drugs Market Share (2017-2018)

Table United States Liver Cirrhosis Therapeutics Drugs Market Size by Type (2013-2018) (Million US$)

Table United States Liver Cirrhosis Therapeutics Drugs Market Share by Type (2013-2018)

Table United States Liver Cirrhosis Therapeutics Drugs Market Size by Application (2013-2018) (Million US$)

Table United States Liver Cirrhosis Therapeutics Drugs Market Share by Application (2013-2018)

Figure Europe Liver Cirrhosis Therapeutics Drugs Market Size 2013-2018 (Million US$)

Table Europe Key Players Liver Cirrhosis Therapeutics Drugs Revenue (2017-2018) (Million US$)

Table Europe Key Players Liver Cirrhosis Therapeutics Drugs Market Share (2017-2018)

Table Europe Liver Cirrhosis Therapeutics Drugs Market Size by Type (2013-2018) (Million US$)

Table Europe Liver Cirrhosis Therapeutics Drugs Market Share by Type (2013-2018)

Table Europe Liver Cirrhosis Therapeutics Drugs Market Size by Application (2013-2018) (Million US$)

Table Europe Liver Cirrhosis Therapeutics Drugs Market Share by Application (2013-2018)

Figure China Liver Cirrhosis Therapeutics Drugs Market Size 2013-2018 (Million US$)

Table China Key Players Liver Cirrhosis Therapeutics Drugs Revenue (2017-2018) (Million US$)

Table China Key Players Liver Cirrhosis Therapeutics Drugs Market Share (2017-2018)

Table China Liver Cirrhosis Therapeutics Drugs Market Size by Type (2013-2018) (Million US$)

Table China Liver Cirrhosis Therapeutics Drugs Market Share by Type (2013-2018)

Table China Liver Cirrhosis Therapeutics Drugs Market Size by Application (2013-2018) (Million US$)

Table China Liver Cirrhosis Therapeutics Drugs Market Share by Application (2013-2018)

Figure Japan Liver Cirrhosis Therapeutics Drugs Market Size 2013-2018 (Million US$)

Table Japan Key Players Liver Cirrhosis Therapeutics Drugs Revenue (2017-2018) (Million US$)

Table Japan Key Players Liver Cirrhosis Therapeutics Drugs Market Share (2017-2018)

Table Japan Liver Cirrhosis Therapeutics Drugs Market Size by Type (2013-2018) (Million US$)

Table Japan Liver Cirrhosis Therapeutics Drugs Market Share by Type (2013-2018)

Table Japan Liver Cirrhosis Therapeutics Drugs Market Size by Application (2013-2018) (Million US$)

Table Japan Liver Cirrhosis Therapeutics Drugs Market Share by Application (2013-2018)

Figure Southeast Asia Liver Cirrhosis Therapeutics Drugs Market Size 2013-2018 (Million US$)

Table Southeast Asia Key Players Liver Cirrhosis Therapeutics Drugs Revenue (2017-2018) (Million US$)

Table Southeast Asia Key Players Liver Cirrhosis Therapeutics Drugs Market Share (2017-2018)

Table Southeast Asia Liver Cirrhosis Therapeutics Drugs Market Size by Type (2013-2018) (Million US$)

Table Southeast Asia Liver Cirrhosis Therapeutics Drugs Market Share by Type (2013-2018)

Table Southeast Asia Liver Cirrhosis Therapeutics Drugs Market Size by Application (2013-2018) (Million US$)

Table Southeast Asia Liver Cirrhosis Therapeutics Drugs Market Share by Application (2013-2018)

Figure India Liver Cirrhosis Therapeutics Drugs Market Size 2013-2018 (Million US$)

Table India Key Players Liver Cirrhosis Therapeutics Drugs Revenue (2017-2018) (Million US$)

Table India Key Players Liver Cirrhosis Therapeutics Drugs Market Share (2017-2018)

Table India Liver Cirrhosis Therapeutics Drugs Market Size by Type (2013-2018) (Million US$)

Table India Liver Cirrhosis Therapeutics Drugs Market Share by Type (2013-2018)

Table India Liver Cirrhosis Therapeutics Drugs Market Size by Application (2013-2018) (Million US$)

Table India Liver Cirrhosis Therapeutics Drugs Market Share by Application (2013-2018)

Figure Central & South America Liver Cirrhosis Therapeutics Drugs Market Size 2013-2018 (Million US$)

Table Central & South America Key Players Liver Cirrhosis Therapeutics Drugs Revenue (2017-2018) (Million US$)

Table Central & South America Key Players Liver Cirrhosis Therapeutics Drugs Market Share (2017-2018)

Table Central & South America Liver Cirrhosis Therapeutics Drugs Market Size by Type (2013-2018) (Million US$)

Table Central & South America Liver Cirrhosis Therapeutics Drugs Market Share by Type (2013-2018)

Table Central & South America Liver Cirrhosis Therapeutics Drugs Market Size by Application (2013-2018) (Million US$)

Table Central & South America Liver Cirrhosis Therapeutics Drugs Market Share by Application (2013-2018)

Table Gilead Sciences Company Details

Table Gilead Sciences Revenue in Liver Cirrhosis Therapeutics Drugs Business (2013-2018) (Million US$)

Figure Gilead Sciences Revenue Growth Rate in Liver Cirrhosis Therapeutics Drugs Business (2013-2018)

Table Gilead Sciences Recent Development

Table GlaxoSmithKline Company Details

Table GlaxoSmithKline Revenue in Liver Cirrhosis Therapeutics Drugs Business (2013-2018)(Million US$)

Figure GlaxoSmithKline Revenue Growth Rate in Liver Cirrhosis Therapeutics Drugs Business (2013-2018)

Table GlaxoSmithKline Recent Development

Table Johnson & Johnson Company Details

Table Johnson & Johnson Revenue in Liver Cirrhosis Therapeutics Drugs Business (2013-2018)(Million US$)

Figure Johnson & Johnson Revenue Growth Rate in Liver Cirrhosis Therapeutics Drugs Business (2013-2018)

Table Johnson & Johnson Recent Development

Table Merck Company Details

Table Merck Revenue in Liver Cirrhosis Therapeutics Drugs Business (2013-2018)(Million US$)

Figure Merck Revenue Growth Rate in Liver Cirrhosis Therapeutics Drugs Business (2013-2018)

Table Merck Recent Development

Table Roche Company Details

Table Roche Revenue in Liver Cirrhosis Therapeutics Drugs Business (2013-2018)(Million US$)

Figure Roche Revenue Growth Rate in Liver Cirrhosis Therapeutics Drugs Business (2013-2018)

Table Roche Recent Development

Table Bristol-Myers Squibb Company Details

Table Bristol-Myers Squibb Revenue in Liver Cirrhosis Therapeutics Drugs Business (2013-2018)(Million US$)

Figure Bristol-Myers Squibb Revenue Growth Rate in Liver Cirrhosis Therapeutics Drugs Business (2013-2018)

Table Bristol-Myers Squibb Recent Development

Table Conatus Pharmaceuticals Company Details

Table Conatus Pharmaceuticals Revenue in Liver Cirrhosis Therapeutics Drugs Business (2013-2018)(Million US$)

Figure Conatus Pharmaceuticals Revenue Growth Rate in Liver Cirrhosis Therapeutics Drugs Business (2013-2018)

Table Conatus Pharmaceuticals Recent Development

Table Gwo Xi Stem Cell Applied Technology Company Details

Table Gwo Xi Stem Cell Applied Technology Revenue in Liver Cirrhosis Therapeutics Drugs Business (2013-2018)(Million US$)

Figure Gwo Xi Stem Cell Applied Technology Revenue Growth Rate in Liver Cirrhosis Therapeutics Drugs Business (2013-2018)

Table Gwo Xi Stem Cell Applied Technology Recent Development

Table Instituto Grifols Company Details

Table Instituto Grifols Revenue in Liver Cirrhosis Therapeutics Drugs Business (2013-2018)(Million US$)

Figure Instituto Grifols Revenue Growth Rate in Liver Cirrhosis Therapeutics Drugs Business (2013-2018)

Table Instituto Grifols Recent Development

Table Intercept Pharmaceuticals Company Details

Table Intercept Pharmaceuticals Revenue in Liver Cirrhosis Therapeutics Drugs Business (2013-2018)(Million US$)

Figure Intercept Pharmaceuticals Revenue Growth Rate in Liver Cirrhosis Therapeutics Drugs Business (2013-2018)

Table Intercept Pharmaceuticals Recent Development

Table NGM Biopharmaceuticals Company Details

Table Norgine Company Details

Table Pharmicell Company Details

Table Salix Pharmaceuticals Company Details

Table Stempeutics Research Company Details

Table Global Liver Cirrhosis Therapeutics Drugs Market Size by Regions (Million US$) 2018-2025

Figure Global Liver Cirrhosis Therapeutics Drugs Market Size Share by Regions (2018-2025)

Figure Global Liver Cirrhosis Therapeutics Drugs Market Size Share by Regions in 2025

Figure United States Liver Cirrhosis Therapeutics Drugs Market Size Forecast (2018-2025)(Million USD)

Figure Europe Liver Cirrhosis Therapeutics Drugs Market Size Forecast (2018-2025)(Million USD)

Figure China Liver Cirrhosis Therapeutics Drugs Market Size Forecast (2018-2025)(Million USD)

Figure Japan Liver Cirrhosis Therapeutics Drugs Market Size Forecast (2018-2025)(Million USD)

Figure Southeast Asia Liver Cirrhosis Therapeutics Drugs Market Size Forecast (2018-2025)(Million USD)

Figure India Liver Cirrhosis Therapeutics Drugs Market Size Forecast (2018-2025)(Million USD)

Figure Central & South America Liver Cirrhosis Therapeutics Drugs Market Size Forecast (2018-2025)(Million USD)

Table Global Liver Cirrhosis Therapeutics Drugs Market Size by Product (2018-2025) (Million US$)

Figure Global Liver Cirrhosis Therapeutics Drugs Market Size by Product (2018-2025)

Figure Global Liver Cirrhosis Therapeutics Drugs Market Size by Product in 2025

Table Global Liver Cirrhosis Therapeutics Drugs Market Size by Application (2018-2025) (Million US$)

Figure Global Liver Cirrhosis Therapeutics Drugs Market Size by Application (2018-2025)

Figure Global Liver Cirrhosis Therapeutics Drugs Market Size by Application in 2025

Table Research Programs/Design for This Report

Figure Bottom-up and Top-down Approaches for This Report

Figure Data Triangulation

Table Key Data Information from Secondary Sources

Table Key Data Information from Primary Sources

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Similar Reports

Medical Implants Market By Type (Orthopedic Implants, cardiac implants, Stents, Spinal Implants, Neurostimulators, dental implants, Breast Implants, facial Implants) and By Materials (Metallic, Ceramic, Polymers, Natural) - Global Opportunity Analysis and Industry Forecast, 2014 - 2022

Medical implants are permanent devices such as pacemakers or temporary devices such as fracture plates which are removed once their function is completed. These implants are made up of bone, tissue, skin, ceramics, metals, plastics, and other natural materials...

  • Publish Date: August 21, 2016
  • $5370
Ostomy Drainage Bags Market by Type (Colostomy Bags, Ileostomy Bags, Urostomy Bags, Continent Urostomy Bags, and Continent Ileostomy Bags) - Global Opportunity Analysis and Industry Forecast, 2014-2022

Ostomy is a surgery wherein an artificial opening, known as stoma, is created from the colon in the human body to eliminate body wastes such as urine, mucus, and stools, which are collected in artificial bags called ostomy drainage bags. These plastic/rub...

  • Publish Date: December 1, 2016
  • $5370